126 related articles for article (PubMed ID: 38496438)
21. ILC2s activated by IL-25 promote antigen-specific Th2 and Th9 functions that contribute to the control of Trichinella spiralis infection.
Angkasekwinai P; Sodthawon W; Jeerawattanawart S; Hansakon A; Pattanapanyasat K; Wang YH
PLoS One; 2017; 12(9):e0184684. PubMed ID: 28898280
[TBL] [Abstract][Full Text] [Related]
22. Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response.
Nevo S; Frenkel N; Kadouri N; Gome T; Rosenthal N; Givony T; Avin A; Peligero Cruz C; Kedmi M; Lindzen M; Ben Dor S; Damari G; Porat Z; Haffner-Krausz R; Keren-Shaul H; Yarden Y; Munitz A; Leshkowitz D; Goldfarb Y; Abramson J
Sci Immunol; 2024 Jan; 9(91):eabq6930. PubMed ID: 38215193
[TBL] [Abstract][Full Text] [Related]
23. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
24. IL-4/IL-13-producing ILC2s are required for timely control of intestinal helminth infection in mice.
Varela F; Symowski C; Pollock J; Wirtz S; Voehringer D
Eur J Immunol; 2022 Dec; 52(12):1925-1933. PubMed ID: 36116042
[TBL] [Abstract][Full Text] [Related]
25. Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.
Banerjee A; Herring CA; Chen B; Kim H; Simmons AJ; Southard-Smith AN; Allaman MM; White JR; Macedonia MC; Mckinley ET; Ramirez-Solano MA; Scoville EA; Liu Q; Wilson KT; Coffey RJ; Washington MK; Goettel JA; Lau KS
Gastroenterology; 2020 Dec; 159(6):2101-2115.e5. PubMed ID: 32828819
[TBL] [Abstract][Full Text] [Related]
26. Tuft cells are required for a rhinovirus-induced asthma phenotype in immature mice.
Li Y; Han M; Singh S; Breckenridge HA; Kreger JE; Stroupe CC; Sawicky DA; Kuo S; Goldsmith AM; Ke F; Shenoy AT; Bentley JK; Matsumoto I; Hershenson MB
JCI Insight; 2024 Jan; 9(2):. PubMed ID: 38061015
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome.
Guggino G; Lin X; Rizzo A; Xiao F; Saieva L; Raimondo S; Di Liberto D; Candore G; Ruscitti P; Cipriani P; Giacomelli R; Dieli F; Alessandro R; Triolo G; Lu L; Ciccia F
Arthritis Rheumatol; 2018 Aug; 70(8):1265-1275. PubMed ID: 29569854
[TBL] [Abstract][Full Text] [Related]
28. IL-25 and CD4(+) TH2 cells enhance type 2 innate lymphoid cell-derived IL-13 production, which promotes IgE-mediated experimental food allergy.
Lee JB; Chen CY; Liu B; Mugge L; Angkasekwinai P; Facchinetti V; Dong C; Liu YJ; Rothenberg ME; Hogan SP; Finkelman FD; Wang YH
J Allergy Clin Immunol; 2016 Apr; 137(4):1216-1225.e5. PubMed ID: 26560039
[TBL] [Abstract][Full Text] [Related]
29. Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling.
Wang L; Luo Y; Luo L; Wu D; Ding X; Zheng H; Wu H; Liu B; Yang X; Silva F; Wang C; Zhang X; Zheng X; Chen J; Brigman J; Mandell M; Zhou Z; Liu F; Yang XO; Liu M
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33104171
[TBL] [Abstract][Full Text] [Related]
30. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
31. A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33.
Lownik JC; Conrad DH; Martin RK
Biochem Biophys Res Commun; 2019 May; 512(4):723-728. PubMed ID: 30926166
[TBL] [Abstract][Full Text] [Related]
32. Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2.
Nakatani-Kusakabe M; Yasuda K; Tomura M; Nagai M; Yamanishi K; Kuroda E; Kanazawa N; Imai Y
JID Innov; 2021 Sep; 1(3):100035. PubMed ID: 34909732
[TBL] [Abstract][Full Text] [Related]
33. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
34. Btn2a2 Regulates ILC2-T Cell Cross Talk in Type 2 Immune Responses.
Frech M; Omata Y; Schmalzl A; Wirtz S; Taher L; Schett G; Zaiss MM; Sarter K
Front Immunol; 2022; 13():757436. PubMed ID: 35145516
[TBL] [Abstract][Full Text] [Related]
35. IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2.
Olguín-Martínez E; Muñoz-Paleta O; Ruiz-Medina BE; Ramos-Balderas JL; Licona-Limón I; Licona-Limón P
Front Immunol; 2022; 13():787713. PubMed ID: 35711429
[TBL] [Abstract][Full Text] [Related]
36. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962
[TBL] [Abstract][Full Text] [Related]
37. CISH constrains the tuft-ILC2 circuit to set epithelial and immune tone.
Kotas ME; Mroz NM; Koga S; Liang HE; Schroeder AW; Ricardo-Gonzalez RR; Schneider C; Locksley RM
Mucosal Immunol; 2021 Nov; 14(6):1295-1305. PubMed ID: 34290377
[TBL] [Abstract][Full Text] [Related]
38. Tuft cell-derived acetylcholine regulates epithelial fluid secretion.
Billipp TE; Fung C; Webeck LM; Sargent DB; Gologorsky MB; McDaniel MM; Kasal DN; McGinty JW; Barrow KA; Rich LM; Barilli A; Sabat M; Debley JS; Myers R; Howitt MR; von Moltke J
bioRxiv; 2023 Mar; ():. PubMed ID: 36993541
[TBL] [Abstract][Full Text] [Related]
39. Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses.
Lok LSC; Walker JA; Jolin HE; Scanlon ST; Ishii M; Fallon PG; McKenzie ANJ; Clatworthy MR
Front Immunol; 2021; 12():711907. PubMed ID: 34484215
[TBL] [Abstract][Full Text] [Related]
40. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions.
Mantani PT; Dunér P; Ljungcrantz I; Nilsson J; Björkbacka H; Fredrikson GN
BMC Immunol; 2019 Dec; 20(1):47. PubMed ID: 31823769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
